[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542405":3},{"organization":4,"armGroups":7,"interventions":48,"overallOfficials":56,"centralContacts":60,"locations":65,"responsibleParty":179,"collaborators":10,"id":181,"slug":182,"hasResults":183,"nctId":184,"briefTitle":185,"officialTitle":186,"acronym":187,"eligibilityCriteria":188,"healthyVolunteers":189,"sex":190,"minAge":191,"maxAge":10,"enrollmentInfo":192,"targetDuration":10,"studyType":195,"phases":10,"briefSummary":196,"conditions":197,"keywords":216,"overallStatus":67,"whyStopped":10,"lastUpdateSubmitDate":229,"lastUpdatePostDateStruct":230,"startDateStruct":233,"completionDateStruct":235,"leadSponsor":237,"locationsCount":238},{"fullName":5,"class":6},"City of Hope Medical Center","OTHER",[8,12,15,18,21,25,29,33,36,39,42,45],{"label":9,"type":10,"description":11,"interventionNames":10},"Non-disease controls (Discovery cohort)",null,"Individuals who underwent colonoscopy and were found not to have any adenomas or cancer.",{"label":13,"type":10,"description":14,"interventionNames":10},"Low-risk Adenoma (Discovery cohort)","Individuals who underwent colonoscopy and were found to only have low-risk adenomas, defined as all of the following:\n\n* 1 to 4 adenomas at most.\n* All adenomas have low-grade dysplasia at most.\n* All adenomas are \\\u003C10 mm in diameter",{"label":16,"type":10,"description":17,"interventionNames":10},"Advanced Adenoma (Discovery cohort)","Individuals who underwent colonoscopy and were found to have high-risk adenomas, defined as one or more of the following:\n\n* 5 or more adenomas.\n* One or more adenomas have high-grade dysplasia.\n* One or more adenomas are \\>10 mm in diameter",{"label":19,"type":10,"description":20,"interventionNames":10},"Colorectal Cancer (Discovery cohort)","Individuals who underwent colonoscopy and were found to have colorectal cancer.",{"label":22,"type":10,"description":11,"interventionNames":23},"Non-disease controls (Training cohort)",[24],"Diagnostic Test: DENEB",{"label":26,"type":10,"description":27,"interventionNames":28},"Low-risk Adenoma (Training cohort)","Individuals who underwent colonoscopy and were found to only have low-risk adenomas, defined as:\n\n* 1 to 4 adenomas at most.\n* All adenomas have low-grade dysplasia at most.\n* All adenomas are \\\u003C10 mm in diameter.",[24],{"label":30,"type":10,"description":31,"interventionNames":32},"Advanced Adenoma (Training cohort)","Individuals who underwent colonoscopy and were found to have high-risk adenomas, defined as one or more of the following:\n\n* 5 or more adenomas.\n* One or more adenomas have high-grade dysplasia.\n* One or more adenomas are \\>10 mm in diameter.",[24],{"label":34,"type":10,"description":20,"interventionNames":35},"Colorectal Cancer (Training cohort)",[24],{"label":37,"type":10,"description":11,"interventionNames":38},"Non-disease controls (Validation cohort)",[24],{"label":40,"type":10,"description":27,"interventionNames":41},"Low-risk Adenoma (Validation cohort)",[24],{"label":43,"type":10,"description":31,"interventionNames":44},"Advanced Adenoma (Validation cohort)",[24],{"label":46,"type":10,"description":20,"interventionNames":47},"Colorectal Cancer (Validation cohort)",[24],[49],{"type":50,"name":51,"description":52,"armGroupLabels":53,"otherNames":54},"DIAGNOSTIC_TEST","DENEB","A panel of circulating microRNA, whose expression level is tested in cell-free and exosome-derived samples.",[30,43,34,46,26,40,22,37],[55],"DENEB (DEtection of colorectal NEoplasias in Blood)",[57],{"name":58,"affiliation":5,"role":59},"Ajay Goel, PhD","PRINCIPAL_INVESTIGATOR",[61],{"name":58,"role":62,"phone":63,"phoneExt":10,"email":64},"CONTACT","6262183452","AJGOEL@COH.ORG",[66,94,107,122,139,157],{"facility":5,"status":67,"city":68,"state":69,"zip":70,"country":71,"countryCode":72,"cosmosGeoPoint":73,"geoPoint":78,"contacts":79},"RECRUITING","Monrovia","California","91016","United States","US",{"type":74,"coordinates":75},"Point",[76,77],-117.99895,34.14806,{"lat":77,"lon":76},[80,82,83,86,88,90,92],{"name":58,"role":62,"phone":81,"phoneExt":10,"email":64},"626-218-3452",{"name":58,"role":59,"phone":10,"phoneExt":10,"email":10},{"name":84,"role":85,"phone":10,"phoneExt":10,"email":10},"Caiming Xu","SUB_INVESTIGATOR",{"name":87,"role":85,"phone":10,"phoneExt":10,"email":10},"Alessandro Mannucci",{"name":89,"role":85,"phone":10,"phoneExt":10,"email":10},"James Lin",{"name":91,"role":85,"phone":10,"phoneExt":10,"email":10},"Gregory Idos",{"name":93,"role":85,"phone":10,"phoneExt":10,"email":10},"Trilokesh Kadambi",{"facility":95,"status":67,"city":96,"state":69,"zip":97,"country":71,"countryCode":72,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"University of California San Diego","San Diego","92093",{"type":74,"coordinates":99},[100,101],-117.16472,32.71571,{"lat":101,"lon":100},[104,106],{"name":105,"role":62,"phone":10,"phoneExt":10,"email":10},"C Richard Boland, MD, PhD",{"name":105,"role":85,"phone":10,"phoneExt":10,"email":10},{"facility":108,"status":67,"city":109,"state":10,"zip":10,"country":110,"countryCode":111,"cosmosGeoPoint":112,"geoPoint":116,"contacts":117},"The First Affiliated Hospital of Dalian Medical University","Dalian","China","CN",{"type":74,"coordinates":113},[114,115],121.60222,38.91222,{"lat":115,"lon":114},[118,120,121],{"name":119,"role":62,"phone":10,"phoneExt":10,"email":10},"Jing Zhang",{"name":119,"role":85,"phone":10,"phoneExt":10,"email":10},{"name":84,"role":85,"phone":10,"phoneExt":10,"email":10},{"facility":123,"status":67,"city":124,"state":10,"zip":10,"country":125,"countryCode":126,"cosmosGeoPoint":127,"geoPoint":131,"contacts":132},"IRCCS San Raffaele","Milan","Italy","IT",{"type":74,"coordinates":128},[129,130],9.18951,45.46427,{"lat":130,"lon":129},[133,136,138],{"name":134,"role":62,"phone":10,"phoneExt":10,"email":135},"Giulia Martina Cavestro, MD, PhD","cavestro.giuliamartina@hsr.it",{"name":137,"role":85,"phone":10,"phoneExt":10,"email":10},"Giulia Martina Cavestro",{"name":87,"role":85,"phone":10,"phoneExt":10,"email":10},{"facility":140,"status":67,"city":141,"state":10,"zip":10,"country":142,"countryCode":143,"cosmosGeoPoint":144,"geoPoint":148,"contacts":149},"Mie University","Mie","Japan","JP",{"type":74,"coordinates":145},[146,147],131.58333,32.96667,{"lat":147,"lon":146},[150,152,153,155],{"name":151,"role":62,"phone":10,"phoneExt":10,"email":10},"Yuji Toiyama",{"name":151,"role":85,"phone":10,"phoneExt":10,"email":10},{"name":154,"role":85,"phone":10,"phoneExt":10,"email":10},"Yoshinaga Okugawa",{"name":156,"role":85,"phone":10,"phoneExt":10,"email":10},"Tadanobu Shimura",{"facility":158,"status":67,"city":159,"state":10,"zip":10,"country":160,"countryCode":161,"cosmosGeoPoint":162,"geoPoint":166,"contacts":167},"Barcelona University","Barcelona","Spain","ES",{"type":74,"coordinates":163},[164,165],2.15899,41.38879,{"lat":165,"lon":164},[168,171,173,175,177],{"name":169,"role":62,"phone":10,"phoneExt":10,"email":170},"Francesc Balaguer, MD, PhD","fprunes@clinic.cat",{"name":172,"role":85,"phone":10,"phoneExt":10,"email":10},"Francesc Balaguer",{"name":174,"role":85,"phone":10,"phoneExt":10,"email":10},"Miguel Pera",{"name":176,"role":85,"phone":10,"phoneExt":10,"email":10},"Lorena Moreno",{"name":178,"role":85,"phone":10,"phoneExt":10,"email":10},"Luis Bujanda",{"type":180,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100542405","early-detection-of-advanced-adenomas-and-colorectal-cancer-100542405",false,"NCT06342440","Early Detection of Advanced Adenomas and Colorectal Cancer","A Liquid Biopsy Assay For The Non-Invasive Early Detection of Advanced Adenomas and Colorectal Cancer","AACRC","Inclusion Criteria:\n\n* All individuals included in the study need to have had a colonoscopy at the time of blood sampling.\n* Received standard diagnostic and staging (as necessary) procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.\n* Received standard pathological and endoscopic diagnosis and assessment for cohort assignment.\n\nExclusion Criteria:\n\n* Hereditary colorectal cancer syndromes (identified through genetic testing).\n* Inflammatory bowel diseases.\n* Lack of written informed consent.",true,"ALL","18 Years",{"count":193,"type":194},2000,"ESTIMATED","OBSERVATIONAL","This study aims to develop a highly sensitive, specific, and cost-effective blood assay for early detection of colorectal adenomas and cancer, using advanced machine learning and state-of-the-art biological analyses.",[198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215],"Colorectal Cancer","Colorectal Neoplasms","Colorectal Polyp","Colorectal Adenocarcinoma","Colorectal Disorders","Colorectal Dysplasia","Colorectal Cancer Stage I","Colorectal Cancer Stage II","Colorectal Cancer Stage III","Colorectal Cancer Stage IV","Colorectal Neoplasms Malignant","Colorectal Serrated Adenocarcinoma","Colorectal Adenoma With Severe Dysplasia","Colorectal Adenoma With Mild Dysplasia","Colorectal Adenoma With Moderate Dysplasia","Colorectal Adenoma and Carcinoma 1","Colorectal Adenomatous Polyp","Colorectal Adenocarcinoma Metastatic in the Liver",[217,218,219,220,221,222,223,224,225,226,227,228],"Early detection","Micro RNA","miRNA","Liquid biopsy","Machine learning","Artificial Intelligence","Incidence","Polypectomy","Screening","Surveillance","Exosome","Vascicles","2026-06-15",{"date":231,"type":232},"2026-06-17","ACTUAL",{"date":234,"type":232},"2020-03-15",{"date":236,"type":194},"2026-06-18",{"name":5,"class":6},6]